Record Numbers of Cancer Drugs Approved- But Leading Experts Say Vital Clinical Trials Could Drop Off Hugely Due To COVID-19

Published May 29, 2020

Record Numbers of Cancer Drugs Approved- But Leading Experts Say Vital Clinical Trials Could Drop Off Hugely Due To COVID-19

There has been a wave of new FDA approved drugs targeted towards cancer patients so far this year, but as the coronavirus pandemic halts current research, future approvals may be in jeopardy

NOW
PLAYING
New PARP Inhibitor Combination Approved for Ovarian Cancer
NOW
PLAYING
People With Blood Cancer Are More Vulnerable to COVID-19
NOW
PLAYING
FDA Approves Blood Test Which May Let Some Cancer Patients Avoid Additional Biopsies
NOW
PLAYING
The 'Right to Try' Act Explained: Cancer Survivor at the RNC Says She’s Alive Thanks to It
NOW
PLAYING
Should Cancer Patients Fly During a Pandemic?
NOW
PLAYING
Cancer Doesn't Mean the End—Senator Harry Reid Talks To SurvivorNet About the Experimental New Therapy That Saved His Life
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.